Benvenue Medical Enrolls 250 Patients in Kyphoplasty Trial

Benvenue Medical has enrolled more than 250 patients in the Kiva System as a Vertebral Augmentation Treatment safety and effectiveness trial.

Advertisement

The study will be the largest randomized study to compare the current standard of care to balloon kyphoplasty for treating vertebral compression fractures related to osteoporosis. The IDE study will support a future FDA 510(k) market clearance application.

More Articles on Orthopedic Devices:

Benvenue Medical Launches Blazer Vertebral Augmentation System

Bacterin Revenue Jumps 96% in 2011

Symmetry Medical Launches 12 Line Enhancements for Retractor System

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.